Application of proactive risk intervention combined with meticulous nursing care in neonatal respiratory distress syndrome
主动风险干预结合精细化护理在新生儿呼吸窘迫综合征患儿中的应用

摘要

目的 深入细致的验证考察主动风险干预结合精细化护理在新生儿呼吸窘迫综合征（NRDS）患儿中的应用效果，旨在为领域研究提供理论与实践依据。方法 研讨期限设立为2023年6月至2024年6月，样本纳入自本时段院内收治的NRDS患儿中，人数共计78例，采用数字编号法进行组别划分，将1-78数字随机排序，单号序列纳入参照组（n=39）：实施常规护理，双号序列纳入研究组（n=39）：实施主动风险干预+精细化护理，最终比对两组干预效果。比对数据包括：临床指标[氧合指数（OI）改善时间、呼吸机使用时间、住院天数、动脉血氧分压（PaO2）、二氧化碳分压（PaCO2）、氧合指数（OI）]、并发症发生率。结果 对比试验的开展实施，均对两组患儿有积极影响效果，相比之下，研究组患儿的各项指标数值体现均显优参照组，P＜0.05。结论 对于NRDS患儿来讲，在其临床护理方案的横向选择过程中，建议优先采纳联合护理模式（主动风险干预+精细化护理）。这种模式不仅能显著提升各项临床指标，还能有效减少并发症发生概率，其应用价值显著，值得推广。

Abstract

Objective To thoroughly verify and investigate the application effect of active risk intervention combined with fine nursing in neonates with Neonatal Respiratory Distress Syndrome (NRDS), so as to provide theoretical and practical basis for field research.
Methods The study period was set from June 2023 to June 2024. A total of 78 NRDS neonates admitted to our hospital during this period were enrolled. Using numerical coding for random grouping, the odd-numbered sequence (n=39) was assigned to the control group receiving routine nursing, and the even-numbered sequence (n=39) to the study group receiving active risk intervention plus fine nursing. The intervention effects were compared between the two groups, including clinical indicators [oxygenation index (OI) improvement time, ventilator use time, hospitalization days, arterial partial pressure of oxygen (PaO2), partial pressure of carbon dioxide (PaCO2), oxygenation index (OI)] and complication rate.
Results The comparative trial showed positive effects on both groups, with all clinical indicators in the study group being significantly superior to those in the control group (P<0.05).
Conclusion   For neonates with NRDS, the combined nursing model (active risk intervention + fine nursing) is recommended as a priority in clinical nursing selection. This model can not only significantly improve clinical indicators but also effectively reduce the incidence of complications, demonstrating remarkable application value worthy of promotion.